WIM JECT
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

WIM JECT Trademark

Serial Number: 79364811 • Registration: 7561392

WIM JECT is a trademark filed by Wirthwein Medical GmbH & Co. KG on November 17, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Wirthwein Medical GmbH & Co. KG (3 trademarks)

Bahnhofstraße 80

Entity Type: 99

Trademark Details

Filing Date

November 17, 2022

Registration Date

November 12, 2024

Published for Opposition

August 27, 2024

Goods & Services

Dental syringes; syringes for medical purposes; medical syringe needles; Medical syringes for injections; medical syringes in the form of pens; Medical insulin syringes in the nature of insulin pens sold empty; disposable nozzles for dental syringes; disposable needles for medical hypodermic syringes; syringes for dental purposes; nozzles for dental syringes; injection syringes for cosmetic surgery; disposable medical syringes for aesthetic treatments; medical venom extraction syringes; hypodermic syringes for use in administering injection substances; medical spinal syringes; medical fluid injectors for medical purposes; hypodermic needles; hypodermic injection apparatus; injection instruments without needles; injection device for pharmaceuticals; injection needles for medical use; injection sleeves for medical use; hypodermic syringes for injections for medical purposes; disposable syringes; disposable hypodermic syringes for surgical use; disposable hypodermic syringes for medical use; cannulae; tubing for use with cannulas; surgical apparatus and instruments; surgical apparatus and instruments for dental use; surgical apparatus and instruments for medical use

pre-filled syringes for medical purposes sold filled with pharmaceuticals for skin care, skin regeneration, skin moisturization, aesthetic treatments, hyaluronic acids, Botulinum toxin and pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; Pre-filled syringes for medical purposes sold filled with pharmaceutical for the treatment of viral diseases, pharmaceutical for infusions, pharmaceutical for injections, diluents, emergency pharmaceuticals, active pharmaceutical ingredients; syringes sold filled with pharmaceuticals for skin care, skin regeneration, skin moisturization, aesthetic treatments, hyaluronic acids, Botulinum toxin and pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; syringes sold filled with pharmaceutical for the treatment of viral diseases, pharmaceutical for infusions, pharmaceutical for injections, diluents, emergency pharmaceuticals, active pharmaceutical ingredients

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 30, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Mar 12, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 3, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 11, 2025 FICS
FINAL DISPOSITION PROCESSED
Apr 11, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 12, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 12, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 12, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 27, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 27, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 24, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 7, 2024 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 7, 2024 NONP
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 7, 2024 OPNR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 24, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 1, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 1, 2024 TROA
REFUSAL PROCESSED BY IB
Jun 3, 2024 RFNT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 30, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 30, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 30, 2024 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 29, 2024 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 23, 2024 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 11, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 22, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 22, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 22, 2024 TROA
REFUSAL PROCESSED BY IB
Oct 17, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 25, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 25, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 6, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 5, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 30, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 21, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 9, 2023 REPR